Abstract
Background: Several demographic, environmental and clinical risk factors have been determined as possible risk/protective factors of Alzheimers disease (AD). The purpose of this study was to find out which one of these known factors is related to developing of AD in Iranian population. Materials and Methods: In a case-control study, 115 elderly patients (mean age of 70±8.18 years) with DSM-IV based final diagnosis compared with 115 non-demented counterparts matched for age ,sex, and socioeconomic status regarding lifestyle, family history, and history of bio-psychosocial health. Results: All differences between the two groups were non-significant except for history of hypertension (P=0.018) which was most prevalent in AD group. Risk of the incident AD for the hypertensive group was 1.71 (1.08-2.70) compared to the non-hypertensive group. Conclusion: These results confirm the previously reported relationship between AD and vascular factors. Prevention, early detection, and treatment of hypertension may have some implications in the primary and secondary prevention of AD.
Keywords: Alzheimer's disease, Risk factors, Hypertension, Smoking, Diabetes mellitus
Current Alzheimer Research
Title: Risk Factors of Alzheimers Disease Among Iranian Population
Volume: 5 Issue: 1
Author(s): Mahshid Foroughan, Zia Ghaemmagham Farahani, Maryam Shariatpanahi, Mehrak Vaezinejad, Ahmad Ali Akbari Kamerani and Mehrdad Sheikhvatan
Affiliation:
Keywords: Alzheimer's disease, Risk factors, Hypertension, Smoking, Diabetes mellitus
Abstract: Background: Several demographic, environmental and clinical risk factors have been determined as possible risk/protective factors of Alzheimers disease (AD). The purpose of this study was to find out which one of these known factors is related to developing of AD in Iranian population. Materials and Methods: In a case-control study, 115 elderly patients (mean age of 70±8.18 years) with DSM-IV based final diagnosis compared with 115 non-demented counterparts matched for age ,sex, and socioeconomic status regarding lifestyle, family history, and history of bio-psychosocial health. Results: All differences between the two groups were non-significant except for history of hypertension (P=0.018) which was most prevalent in AD group. Risk of the incident AD for the hypertensive group was 1.71 (1.08-2.70) compared to the non-hypertensive group. Conclusion: These results confirm the previously reported relationship between AD and vascular factors. Prevention, early detection, and treatment of hypertension may have some implications in the primary and secondary prevention of AD.
Export Options
About this article
Cite this article as:
Foroughan Mahshid, Farahani Ghaemmagham Zia, Shariatpanahi Maryam, Vaezinejad Mehrak, Akbari Kamerani Ali Ahmad and Sheikhvatan Mehrdad, Risk Factors of Alzheimers Disease Among Iranian Population, Current Alzheimer Research 2008; 5 (1) . https://dx.doi.org/10.2174/156720508783884594
DOI https://dx.doi.org/10.2174/156720508783884594 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hyperuricaemia and Non-Alcoholic Fatty Liver Disease (NAFLD): A Relationship with Implications for Vascular Risk?
Current Vascular Pharmacology A Special Focus on Selexipag - Treatment of Pulmonary Arterial Hypertension
Current Pharmaceutical Design Editorial
Current Rheumatology Reviews Antihypertensive Effect of Sesamin
Vascular Disease Prevention (Discontinued) Emerging Risk Factors for Cerebrovascular Disease
Current Drug Targets Molecular Mechanism of Aggravation of Hypertensive Organ Damages by Short-Term Blood Pressure Variability
Current Hypertension Reviews PARP Inhibitor Drugs in the Treatment of Breast, Ovarian, Prostate and Pancreatic Cancers: An Update of Clinical Trials
Current Drug Targets Standards and Novel Therapeutic Options in the Treatment of Patients with Soft Tissue Sarcoma
Reviews on Recent Clinical Trials The Application of NMR Spectroscopy for the Study of Heart Failure
Current Pharmaceutical Design NTproBNP: An Important Biomarker in Cardiac Diseases
Current Topics in Medicinal Chemistry Stable Gastric Pentadecapeptide BPC 157-NO-system Relation
Current Pharmaceutical Design Screening for Inhibitors of Microglia to Reduce Neuroinflammation
CNS & Neurological Disorders - Drug Targets Tissue Plasminogen Activator (tPA) and Matrix Metalloproteinases in the Pathogenesis of Stroke: Therapeutic Strategies
CNS & Neurological Disorders - Drug Targets Development of Functional Dark Chocolate by Incorporating Flaxseed (Linum usitatissimum) Oil and Honey with Improved Organoleptic and Textural Attributes
Current Nutrition & Food Science Liver and Pancreatic Disease in Cystic Fibrosis: Clinics and Drug Therapy
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Side Effects of Clozapine and Some Other Psychoactive Drugs
Current Drug Safety JAK2 as a Molecular Marker in Myeloproliferative Diseases
Cardiovascular & Hematological Agents in Medicinal Chemistry Arterial Spin Labeling Perfusion MRI in Alzheimers Disease
Current Medical Imaging Metabolic Syndrome and Aging: Calcium Signaling as Common Regulator
Current Diabetes Reviews Pharmacodynamic Evaluation of Novel Tetrandrine-loaded Chitosan Microspheres
Letters in Drug Design & Discovery